The Human IL-21 Antibody is a SULFO-TAG-conjugated detection antibody for IL-21. It is the same detection antibody that is in the V-PLEX Human IL-21 Assay. Detection antibody is supplied as a 50X concentrated solution. Interleukin-21 is a key component of the Th17 pathway, is implicated in many autoimmune disorders, and is a biomarker for Hodgkin's lymphoma.
    
    
 
    
    
    
        
                
            
                - 
                    
                
 
            
                - 
                    Specifications
                
 
            
                - 
                    
                
 
            
                - 
                    
                
 
            
                - 
                    References
                
 
            
                
            
        
            
                    
                    
                
                    
                    
                        
	
    
            
        
            
                | 
                    Analyte(s)
                    
                    
                        
                            
                        
                    
                 | 
                 | 
                
                    
                            IL-21
                        
                 | 
                 | 
            
        
            
                | 
                    Usage Statement
                    
                    
                        
                            
                        
                    
                 | 
                 | 
                
                    
                            For Research Use Only. Not for use in diagnostic procedures.
                        
                 | 
                 | 
            
        
            
                | 
                    Storage Condition
                    
                    
                        
                            
                        
                    
                 | 
                 | 
                
                    
                            2-8 °C
                        
                 | 
                 | 
            
        
            
                | 
                    Schedule B Code
                    
                    
                        
                            
                        
                    
                 | 
                 | 
                
                    
                            3822.19.0000
                        
                 | 
                 | 
            
        
            
        
 
                     
                
                    
                    
                        
                    
                
                    
                    
                        
                    
                
                    
                    
                        
	
    
        
            
                | 
                    Title
                 | 
                
                    Journal
                 | 
                
                    Year
                 | 
                 | 
            
            
                    
                        
                            
                                Reliability of self-sampling for accurate assessment of respiratory virus viral and immunologic kinetics
                             
                            
                         | 
                        
                            
                                
                         | 
                        
                            
                         | 
                        
                            
                                 
                            
                         | 
                    
                
                    
                        
                            
                                Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity
                             
                            
                         | 
                        
                            
                                
                         | 
                        
                            
                         | 
                        
                            
                                 
                            
                         | 
                    
                
            
                | 
                     
                        
                     
                    
                 |